GST-HG151

N/A

Report date: 2024/01/05 15:44:06
NME

Base Information

Drug NameGST-HG151
Drug Alias NameGST-HG151
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitorsP38 mitogen-activated protein kinase stimulants
Targetsc-Jun N-terminal kinaseP38 mitogen-activated protein kinase
Therapy Area/IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFujian Cosunter Pharmaceutical Co LtdWuxi Apptec Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesFujian Cosunter Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A